Genprex (GNPX) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

What defines a successful crypto expert? The amount of money earned, the number of luxury cars and international real estate? The presence of…
Features of exchanging USDC ERC20 to Bank Transfer

March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer

You can use electronic exchange services if you need to exchange the digital asset USDC ERC20 to Bank Transfer. It is not recommended…
Why Stock Caps Matter When Building a Diversified Portfolio

February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio

Most investors who want to expand their investment options put their money in different asset types and industries across many areas in the…
Top 5 Coins for the Maximum Passive Income from Staking by 2024

February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024

Staking is one of the ways that is now being used as a secure and profitable way to earn money without doing anything…
Trading Stocks With AI: A Modern Approach

January 21, 2025 Trading Stocks With AI: A Modern Approach

The stock market can feel overwhelming, especially with its constant ups and downs. Trading stocks with AI is revolutionizing how investors analyze trends,…

Genprex (GNPX) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: May 22, 2025 (04:43)

Sector: Healthcare

The share price of Genprex, Inc. (GNPX) now

Latest session on the 21st of May for
Genprex, Inc. is negative
Trading Volume: 871106
Open: 0.297 /  High: 0.3 /  Low: 0.27
Current value: $0.278
What analysts predict: $7.5
52-week High/Low: $4.09 / $0.215
50-Day Moving Average: $0.298 — resistance level today
200-Day Moving Average: $0.729 — resistance level today

Are you interested in Genprex, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Genprex stock price in 2025, 2026, 2027. How much will one Genprex share be worth in 2025 - 2027?

When should I take profit in Genprex stock? When should I record a loss on Genprex stock? What are analysts' forecasts for Genprex stock? What is the future of Genprex stock? We forecast Genprex stock performance using neural networks based on historical data on Genprex stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Genprex stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Genprex shares. This happens once a day.


Historical and forecast chart of Genprex stock

The chart below shows the historical price of Genprex stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Genprex stock price can be found in the table below.

Long-term forecasts by years.

Genprex, Inc. Is a clinical gene therapy company. The company is focused on developing oncology based on its new technology platform, including its initial candidate product, Oncoprex, immunogenotherapy or Oncoprex. Oncoprex consists of a tumor suppressor gene introduced into the cells of a patient, which has an immunomodulatory effect and is thus considered an immunogenic therapy. The gene is one of a number of genes licensed for therapeutic use by the University of Texas MD Anderson Cancer Center (MD Anderson). It is also developing preclinical gene therapy licensed by the University of Pittsburgh Commonwealth Higher Education System, which has the potential to treat type 1 and type 2 diabetes. He is developing his candidate product for use with targeted therapy and immunotherapy for non-small cell lung cancer (NSCLC).

Trending Themes in the Healthcare Sector

Genprex daily forecast for a month

Date Target Pes. Opt. Vol., %
May 24 0.35 0.32 0.37 15.18
May 25 0.36 0.33 0.37 14.57
May 26 0.35 0.33 0.38 17.17
May 27 0.35 0.33 0.38 14.63
May 28 0.40 0.38 0.43 12.57
May 29 0.39 0.37 0.43 15.95
May 30 0.41 0.37 0.44 20.58
May 31 0.41 0.38 0.44 14.45
Jun 01 0.45 0.41 0.49 18.72
Jun 02 0.41 0.39 0.43 9.00
Jun 03 0.36 0.35 0.39 12.53
Jun 04 0.40 0.36 0.43 19.19
Jun 05 0.39 0.36 0.44 21.71
Jun 06 0.44 0.41 0.47 13.57
Jun 07 0.49 0.46 0.54 19.33
Jun 08 0.49 0.45 0.54 19.95
Jun 09 0.56 0.54 0.60 11.13
Jun 10 0.62 0.59 0.67 13.84
Jun 11 0.54 0.51 0.56 9.17
Jun 12 0.52 0.49 0.56 16.25
Jun 13 0.49 0.46 0.52 13.59
Jun 14 0.46 0.40 0.47 17.56
Jun 15 0.50 0.44 0.53 19.88
Jun 16 0.51 0.45 0.56 24.05
Jun 17 0.51 0.47 0.57 20.31
Jun 18 0.50 0.48 0.54 12.84
Jun 19 0.50 0.48 0.54 14.34
Jun 20 0.48 0.45 0.53 17.16
Jun 21 0.48 0.46 0.54 16.49
Jun 22 0.45 0.41 0.46 13.45

Genprex Daily Price Targets


Genprex Stock Forecast 05-24-2025.

Forecast target price for 05-24-2025: $0.35.
Positive dynamics for Genprex shares will prevail with possible volatility of 13.176%.
Pessimistic target level: 0.32
Optimistic target level: 0.37

Genprex Stock Forecast 05-25-2025.

Forecast target price for 05-25-2025: $0.36.
Positive dynamics for Genprex shares will prevail with possible volatility of 12.720%.
Pessimistic target level: 0.33
Optimistic target level: 0.37

Genprex Stock Forecast 05-26-2025.

Forecast target price for 05-26-2025: $0.35.
Negative dynamics for Genprex shares will prevail with possible volatility of 14.657%.
Pessimistic target level: 0.33
Optimistic target level: 0.38

Genprex Stock Forecast 05-27-2025.

Forecast target price for 05-27-2025: $0.35.
Positive dynamics for Genprex shares will prevail with possible volatility of 12.760%.
Pessimistic target level: 0.33
Optimistic target level: 0.38

Genprex Stock Forecast 05-28-2025.

Forecast target price for 05-28-2025: $0.40.
Positive dynamics for Genprex shares will prevail with possible volatility of 11.163%.
Pessimistic target level: 0.38
Optimistic target level: 0.43

Genprex Stock Forecast 05-29-2025.

Forecast target price for 05-29-2025: $0.39.
Negative dynamics for Genprex shares will prevail with possible volatility of 13.753%.
Pessimistic target level: 0.37
Optimistic target level: 0.43

GNPX (GNPX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jun. 0.28 0.22 0.39 44.20
Jul. 0.22 0.15 0.25 37.55
Aug. 0.16 0.12 0.23 46.07
Sep. 0.09 0.08 0.13 42.03
Oct. 0.10 0.07 0.14 49.09
Nov. 0.11 0.08 0.14 42.97
Dec. 0.16 0.10 0.21 50.78

Genprex forecast for this year


Genprex Stock Prediction for Jun 2025

An uptrend is forecast for this month with an optimal target price of $0.27945. Pessimistic: $0.22. Optimistic: $0.39


Genprex Stock Prediction for Jul 2025

An downtrend is forecast for this month with an optimal target price of $0.215176. Pessimistic: $0.15. Optimistic: $0.25


Genprex Stock Prediction for Aug 2025

An downtrend is forecast for this month with an optimal target price of $0.163534. Pessimistic: $0.12. Optimistic: $0.23


Genprex Stock Prediction for Sep 2025

An downtrend is forecast for this month with an optimal target price of $0.0940321. Pessimistic: $0.08. Optimistic: $0.13


Genprex Stock Prediction for Oct 2025

An uptrend is forecast for this month with an optimal target price of $0.104846. Pessimistic: $0.07. Optimistic: $0.14


Genprex Stock Prediction for Nov 2025

An uptrend is forecast for this month with an optimal target price of $0.110088. Pessimistic: $0.08. Optimistic: $0.14


Genprex Stock Prediction for Dec 2025

An uptrend is forecast for this month with an optimal target price of $0.160178. Pessimistic: $0.10. Optimistic: $0.21



Genprex (GNPX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 0.14 0.10 0.17 40.93
Feb 0.17 0.12 0.20 38.46
Mar 0.18 0.16 0.21 25.42
Apr 0.21 0.15 0.23 34.55
May 0.24 0.18 0.30 39.60
Jun 0.25 0.16 0.31 46.53
Jul 0.28 0.19 0.37 48.50
Aug 0.33 0.25 0.46 45.65
Sep 0.48 0.40 0.63 35.98
Oct 0.46 0.29 0.61 52.45
Nov 0.52 0.45 0.60 25.64
Dec 0.69 0.51 0.89 42.86

Genprex (GNPX) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 0.78 0.70 1.00 30.23
Feb 0.57 0.45 0.73 38.28
Mar 0.64 0.45 0.87 47.97
Apr 0.80 0.59 0.90 34.96
May 0.84 0.62 1.03 39.84
Jun 1.09 0.97 1.26 22.84
Jul 1.19 1.02 1.37 25.33
Aug 1.27 1.13 1.74 35.40
Sep 0.72 0.48 0.82 41.67
Oct 0.88 0.65 1.04 37.71
Nov 0.54 0.34 0.71 52.63
Dec 0.59 0.37 0.66 43.05

Genprex information and performance

Genprex Address

100 CONGRESS AVENUE, SUITE 2000, AUSTIN, TX, US

Market Capitalization: 7 511 700 $

Market capitalization of the Genprex, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GNPX shares in the company outstanding by the market price of one share.

EBITDA: -21 167 474 $

EBITDA of Genprex is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -5.34

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: 0.182

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 24152800

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about Genprex Stock)

Should I Buy Genprex Shares in 2025 year?

The maximum forecasted share price for next year is $0.69, which is $0.41 higher than the current stock price. By investing in Genprex shares today for a one-year period, you could achieve a profit of 146.54%. With an investment horizon of up to two years, the target share price is $1.27. resulting in a profit of 357.58% ($0.99 per share).

Does Genprex pay dividends?

No, it does not

Which economic sector do Genprex's shares belong to?

Genprex's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Genprex's shares?

You can view all the stocks that are part of the same sector as Genprex's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.